Clinical Trials Browser

Phase NA × Bevacizumab × 30 days × Clear all

NCT04180072 2026-04-09

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Phase NA Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04446416 2026-04-09

Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

Phase NA Completed

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT07466238 2026-04-08

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Phase NA Recruiting

Gastrointestinal

Biliary Tract Neoplasms